C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.
about
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskC2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the BrainThe Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine.The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.
P2860
C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@en
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@nl
type
label
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@en
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@nl
prefLabel
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@en
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@nl
P2093
P2860
P50
P356
P1476
C2238/αANP modulates apolipopr ...... smooth muscle cells in vitro.
@en
P2093
P2860
P356
10.1038/CDDIS.2015.370
P50
P577
2015-12-31T00:00:00Z